Cubist Systematic Strategies LLC Raises Stock Position in Aurora Cannabis Inc. $ACB

Key Points

• Cubist Systematic Strategies LLC increased its ownership in Aurora Cannabis Inc. by 358.6%, owning a total of 238,460 shares valued at about $1,047,000 as of the most recent SEC filing.
• Aurora Cannabis reported a loss of ($0.19) EPS for the past quarter, missing the consensus estimate significantly, and had revenue of $71.98 million, below expectations of $96.83 million.
• Following multiple analyst reports, Aurora Cannabis has a consensus rating of "Buy", with two analysts rating it as Strong Buy and one as Sell.

Cubist Systematic Strategies LLC lifted its stake in shares of Aurora Cannabis Inc. (NASDAQ:ACB - Free Report) by 358.6% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 238,460 shares of the company's stock after acquiring an additional 186,462 shares during the period. Cubist Systematic Strategies LLC owned 0.42% of Aurora Cannabis worth $1,047,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. JW Asset Management LLC bought a new position in Aurora Cannabis during the first quarter worth $58,000. Cobblestone Asset Management LLC bought a new position in Aurora Cannabis during the first quarter worth $67,000. Millennium Management LLC bought a new position in Aurora Cannabis during the fourth quarter worth $67,000. State of Wyoming bought a new position in shares of Aurora Cannabis in the first quarter valued at $94,000. Finally, Mackenzie Financial Corp lifted its stake in shares of Aurora Cannabis by 8.9% in the first quarter. Mackenzie Financial Corp now owns 27,783 shares of the company's stock valued at $122,000 after buying an additional 2,280 shares in the last quarter. 47.63% of the stock is owned by institutional investors.

Aurora Cannabis Stock Performance

NASDAQ ACB traded down $0.06 on Friday, hitting $4.87. 651,189 shares of the stock traded hands, compared to its average volume of 1,275,003. The business's fifty day moving average is $4.84 and its two-hundred day moving average is $4.78. Aurora Cannabis Inc. has a 12 month low of $3.42 and a 12 month high of $6.91. The firm has a market capitalization of $274.93 million, a price-to-earnings ratio of -25.63 and a beta of 1.91. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.51 and a current ratio of 2.97.

Aurora Cannabis (NASDAQ:ACB - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of $0.18 by ($0.37). The business had revenue of $71.98 million for the quarter, compared to analysts' expectations of $96.83 million. Aurora Cannabis had a negative net margin of 5.66% and a negative return on equity of 1.49%. As a group, equities analysts anticipate that Aurora Cannabis Inc. will post 0.46 EPS for the current fiscal year.

Analyst Ratings Changes

ACB has been the topic of a number of recent research reports. Zacks Research raised shares of Aurora Cannabis to a "strong sell" rating in a research note on Friday, August 8th. Wall Street Zen lowered shares of Aurora Cannabis from a "hold" rating to a "sell" rating in a research note on Friday, July 18th. Two research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy".

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.